Business Insights and Analytics

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Read more

Strategic and Scientific Consulting

Our Consulting team help solve complex scientific and commercial challenges and drive strategy throughout the product lifecycle

Read more

Scientific and Creative Communications

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Read more

Business Insights and Analytics

Plus icon

Our Insight team applies rigorous analysis and expert interpretation in order to provide strategic recommendations

Read more

Strategic and Scientific Consulting

Plus icon

Our Consulting team help solve complex scientific and commercial challenges and drive strategy throughout the product lifecycle

Read more

Scientific and Creative Communications

Plus icon

Our Communications team care passionately about the science and making evidence matter across the entire healthcare spectrum

Read more

Why we do what we do

The healthcare industry is going through fundamental change and in this uncertainty our clients need to convert great science into winning strategy

Our clients tell us they need our support in making the right strategic decisions that ensure their products fulfill their potential and ultimately improve people’s lives

We love working at the cutting edge, helping to tackle our clients’ newest and most complex problems

Teams of experts

We are expert navigators helping guide our clients to more successful outcomes

With a global perspective

We work with 24 of the top 25 pharmaceutical companies as well as 100s of biotechs globally from our offices in the US and Europe

Solving unique problems

Whether we are supporting you on your journey, or delivering specialist expertise, we are helping you make important choices

Share our fresh thinking >

Insights into self-commercialization and the need for earlier commercial planning with Biotech leaders
In early February, Cello Health Consulting’s Carl Engleman moderated another lively panel discussion with senior biotech leaders at the LSX World Conference.
Proliferation of Novel Cell Type Platforms in the Oncology Competitive Landscape-Part II
Perhaps more so than any other modality to date, cancer cell therapies have captured the imaginations and wherewithal of industry, investor, and oncologist communities alike.
Differentiating in oncology. Are you being clear?
Oncology markets continue to rapidly evolve and grow. New entrants with novel mechanisms of action and a wealth of new data mean patient outcome goals are more varied and treatment options more complex.
Detour or new direction? Future-proofing patient journeys
There is much talk of the old and new normal, but the reality of the future will be a blend of the two, and the patients’ journey with their disease will have a different shape going forward.

Let’s work together

The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us today.